| Reduced Risk Status: |
|
| IPM Compatibility: |
FROM REQUESTOR: VERY GOOD IPM FIT; GROWERS ARE CURRENTLY USING INEFFECTIVE PRODUCTS:09/16
|
| Reasons for need: |
PYTHIUM ROOT ROT
|
| Requesting State(s): |
MI:Hausbeck, M ;
|
| PCR Use Pattern: |
USE PRESIDIO PRODUCT; MAKE 2 SOIL DRENCH APPLIC TO GH FLATS OF SEEDLINGS, USING 4 FL OZ PRODUCT/100 GAL, 14-DAY INTERVAL
|
| EPA Default Residue Trials: |
|
| IR-4 Residue Trial Plan: |
3-2 5 10-5
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
THERE IS A LEAFY VEG (EXCEPT BRASSICA) GROUP 4 TOLERANCE; THIS REQUESTED USE IS FOR GH TRANSPLANTS THAT WILL BE SOLD RETAIL TO CONSUMERS:09/16; MFG NEEDS TO SEE E/CS DATA BEFORE APPROVAL FOR RESIDUE WORK; PER MFG, ETHABOXAM MAY BE A BETTER FIT FOR THIS NEED:05/17; TREATMENT IS GH AND THEN SENDING TO A RETAIL LOCATION TO BE TRANSPLANTED; SO WE MUST NEED DO TRIALS IN REGIONS THAT ARE REQUIRED FOR A CELERY FIELD USE TO SHOW NO RESDIUES:05/22; during the 2025 FUW, Valent advised to update status from Potential to (Mfg) Hold:09/25/sb; with mgmt approval, commodity of Celery (GH Transplant, Field) was updated to Celery (GH Transplant) after confirmation from requester that trt will only occur in GH, then for retail sale to consumer:02/26/sb;
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|